We are live on ! Find out more
ESLA icon

Estrella Immunopharma
ESLA

22 hedge funds and large institutions have $33.9M invested in Estrella Immunopharma in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $29M → $33.9M (+$4.91M)

5% more funds holding

Funds holding: 21 → 22 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11.49% less ownership

Funds ownership: 69.44% → 57.95% (-11%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
+$2.18M
2
OFG
OTA Financial Group
New York
+$56.6K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$1.24M
2
KIM
Karpus Investment Management
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
KIM
1
Karpus Investment Management
New York
$8.63M -$1K -100 -0%
ASM
2
ATW SPAC Management
New York
$3.9M – – –
BFM
3
Boothbay Fund Management
New York
$3.9M – – –
HHGC
4
Hunting Hill Global Capital
New York
$2.9M – – –
CSS
5
Cubist Systematic Strategies
Connecticut
$2.17M +$2.18M +216,895 New
Nomura Holdings
6
Nomura Holdings
Japan
$1.98M – – –
CH
7
CVI Holdings
Delaware
$1.76M – – –
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$1.75M – – –
Goldman Sachs
9
Goldman Sachs
New York
$1.07M – – –
RCM
10
Radcliffe Capital Management
Pennsylvania
$1M – – –
PNC Financial Services Group
11
PNC Financial Services Group
Pennsylvania
$934K – – –
WA
12
Whitebox Advisors
Minnesota
$910K – – –
Citigroup
13
Citigroup
New York
$620K – – –
WRBC
14
W.R. Berkley Corp
Connecticut
$544K – – –
OFG
15
OTA Financial Group
New York
$503K +$56.6K +5,639 +13%
LA
16
Linden Advisors
New York
$416K -$1.24M -123,876 -75%
PCM
17
Pinz Capital Management
New York
$241K – – –
LCM
18
Landscape Capital Management
New Jersey
$207K – – –
Janus Henderson Group
19
Janus Henderson Group
United Kingdom
$174K – – –
SSA
20
Schonfeld Strategic Advisors
New York
$113K – – –
Millennium Management
21
Millennium Management
New York
$100K – – –
WAM
22
Weiss Asset Management
Massachusetts
$100K – – –

ESLA Hedge Fund Activity: Q2 2022 in Review

22 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma (ESLA) for Q2 2022, worth a combined $33.9M — up 17% from $29M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ESLA positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Cubist Systematic Strategies, opening a new position worth an estimated $2.18M. The largest seller was Linden Advisors, cutting an estimated $1.24M.

  • 22 institutional investors held Estrella Immunopharma (ESLA) as of Q2 2022, up from 21 in Q1 2022.
  • Funds reported $33.9M of Estrella Immunopharma stock for Q2 2022, up 17% quarter-over-quarter.
  • 1 fund opened new Estrella Immunopharma positions in Q2 2022 and 0 closed out, a net change of +1 holder.
  • The largest Estrella Immunopharma buyer in Q2 2022 was Cubist Systematic Strategies, an estimated $2.18M added.
  • The largest Estrella Immunopharma seller in Q2 2022 was Linden Advisors, an estimated $1.24M sold.

Based on aggregated 13F filings for Q2 2022.